Women's health - Congressional Report: FDA Broke Own Protocols in Approving Biogen Alzheimer's Drug

The FDA failed to adhere to its own guidance and internal practices during the approval process for Biogen's Alzheimer's drug Aduhelm, which was 'rife with irregularities,' a...